Logo HealthEquity

HealthEquity (HQY) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
HealthEquity · Health Care · ref. ETF XLV · 84 calls · price $90.19
🏆JPI 2026 portfoliosSee tracking →
What the company does: HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.

📈 HealthEquity (HQY) stock price

$90.19-4.1% over range
Oct 14, 25low $73.21 · high $106.79Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 6 analysts
📊 JPI status : HealthEquity has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 HQY price target & analyst consensus — price $90.19

The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$142+57.4%
Median target · of 6 targets$113+25.3%
Lowest target · 1 firm of 6$108+19.7%
Current price$90.19
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 6100% $108 ↔ $142
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Deutsche Bank — 68% of its targets hit on this sector (80 calls tested). It aims for $142 (+57 %), call made on September 1, 2026, maturing on September 1, 2027 (43 d ago).

The 2 reliable analysts $129+43 %
The 4 other firms $111+23 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $129 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about HealthEquity? The JPI assistant answers using our backtest data.

📈 HealthEquity fundamentals: valuation, margins & growth › open the full page

P/E 32.6Net margin 17.4 %Revenue growth +7.6 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2023
marg. -3 %
2024
Rev +16%
2025
Rev +20%Profit +74%
2026
Rev +9%Profit +123%

🔎 Detailed analyses

🏛️ Which US Congress members hold HealthEquity (HQY)?

3 Congress members have disclosed HQY buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Blake Moore 4× · 39%Josh Gottheimer 4× · 56%Gilbert Cisneros 3× · 48%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on HQY

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Chardan Capital 100% +24.2% 4
Baird ↗ 100% +22.9% 2
Oppenheimer ↗ 100% +14.8% 2
SVB Leerink 100% +0.8% 2
JP Morgan ↗ 86% +23.7% 7
Cantor Fitzgerald ↗ 83% +33.4% 6
RBC Capital ↗ 80% +12.6% 15
JMP Securities 80% +5.9% 5
B of A Securities ↗ 71% +5.2% 7
SunTrust Robinson Humphrey 67% +35.6% 6
See the other 9 firms
Jefferies ↗ 25% -3.5% 4
Keybanc ↗ 56% +2.0% 16
Raymond James ↗ 56% +7.2% 18
Deutsche Bank ↗ 56% +11.4% 18
Leerink Swann 60% +34.6% 5
Barrington Research ↗ 61% +14.4% 18
Wells Fargo ↗ 62% +5.9% 16
BTIG ↗ 67% -2.9% 3
Guggenheim ↗ 67% +12.0% 3

📊 What $1,000 invested in HealthEquity would be worth › open the full page

In short — $1,000 invested in HealthEquity 10 years ago would be worth $3,603 today, i.e. +14%/yr on average. Best year: 2016 (+62%), worst: 2021 (-37%). Price performance, excluding dividends.

If I'd invested $1,000 in HealthEquity

InvestmentWorth todayGain
1 years ago$941-6%
3 years ago$1,465+47%
5 years ago$1,296+30%
→ See HealthEquity's full return history + gain calculator

Return by year (HealthEquity)

YearReturn$1,000 invested at year start
2026 (YTD)-1%$986 (-1%)
2025-5%$941 (-6%)
2024+45%$1,362 (+36%)
→ See HealthEquity's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on HealthEquity

Loading news…

📋 All analyst calls on HQY

Barclays ↗
Sep 18, 26
▲ Overweight · 🎯$115
Price at call : $95.14 — upside +21%
Today : $90.19 — upside +28%
🎯 on HQY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Sep 18, 27
Deutsche Bank ↗
Aug 31, 26
▲ Buy · 🎯$142
Price at call : $97 — upside +46%
Today : $90.19 — upside +57%
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
in progress (365j)
matures : Aug 31, 27
BTIG ↗
Aug 28, 26
▲ Buy · 🎯$115
Price at call : $96.37 — upside +19%
Today : $90.19 — upside +28%
🎯 on HQY : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Aug 28, 27
BTIG ↗
Jul 24, 26
▲ Buy · 🎯$115
Price at call : $94.64 — upside +22%
Today : $90.19 — upside +28%
🎯 on HQY : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Jul 24, 27
RBC Capital ↗
Jun 3, 26
▲ Outperform · 🎯$108
Price at call : $86.03 — upside +26%
Today : $90.19 — upside +20%
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jun 3, 27
Citizens
Jun 1, 26
▲ Market Outperform · 🎯$111
Price at call : $88.34 — upside +26%
Today : $90.19 — upside +23%
🎯 on HQY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 1, 27
RBC Capital ↗
May 29, 26
▲ Outperform · 🎯$108
Price at call : $90.64 — upside +19%
Today : $90.19 — upside +20%
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : May 29, 27
▲ Outperform · 🎯$110
Price at call : $87.25 — upside +26%
Today : $90.19 — upside +22%
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : May 22, 27
See the other 76 calls, newest to oldest
BMO Capital ↗
Apr 9, 26
▲ Outperform · 🎯$105
Price at call : $84.2 — upside +25%
Today : $90.19 — upside +16%
🎯 on HQY : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Apr 9, 27
Deutsche Bank ↗
Mar 19, 26
▲ Buy · 🎯$128
Price at call : $81.02 — upside +58%
Today : $90.19 — upside +42%
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
in progress (365j)
matures : Mar 19, 27
▲ Outperform · 🎯$110
Price at call : $81.13 — upside +36%
Today : $90.19 — upside +22%
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Mar 18, 27
JP Morgan ↗
Mar 18, 26
▲ Overweight · 🎯$123
Price at call : $81.13 — upside +52%
Today : $90.19 — upside +36%
🎯 on HQY : 0% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Mar 18, 27
RBC Capital ↗
Mar 18, 26
▲ Outperform · 🎯$100
Price at call : $81.13 — upside +23%
Today : $90.19 — upside +11%
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Mar 18, 27
Barclays ↗
Feb 18, 26
▲ Overweight · 🎯$110
Price at call : $78.88 — upside +39%
Today : $90.19 — upside +22%
🎯 on HQY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 18, 27
BTIG ↗
Feb 17, 26
▲ Buy · 🎯$110
Price at call : $74.36 — upside +48%
Today : $90.19 — upside +22%
🎯 on HQY : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 17, 27
Goldman Sachs ↗
Jan 9, 26
▼ Sell · 🎯$89
Price at call : $94.15 — upside -5%
Today : $90.19 — upside -1%
🎯 on HQY : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Jan 9, 27
Keybanc ↗
Jan 8, 26
▲ Overweight · 🎯$125
Price at call : $98.51 — upside +27%
Today : $90.19 — upside +39%
🎯 on HQY : 67% (3 calls matureds) · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Jan 8, 27
Barclays ↗
Dec 9, 25
▲ Overweight · 🎯$118
Price at call : $95.73 — upside +23%
Today : $90.19 — upside +31%
🎯 on HQY : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Dec 9, 26
▲ Outperform · 🎯$125
Price at call : $94.51 — upside +32%
Today : $90.19 — upside +39%
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
in progress (365j)
matures : Dec 4, 26
JP Morgan ↗
Dec 4, 25
▲ Overweight · 🎯$129
Price at call : $94.51 — upside +36%
Today : $90.19 — upside +43%
🎯 on HQY : 0% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Dec 4, 26
Citizens
Dec 4, 25
▲ Market Outperform · 🎯$122
Price at call : $95.67 — upside +28%
Today : $90.19 — upside +35%
🎯 on HQY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 4, 26
BTIG ↗
Dec 4, 25
▲ Buy · 🎯$130
Price at call : $95.67 — upside +36%
Today : $90.19 — upside +44%
🎯 on HQY : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Dec 4, 26
BMO Capital ↗
Nov 13, 25
■ Market Perform neutral · not a buy · 🎯$100
Price at call : $99.5 — gap to target +1%
Today : $90.19 — gap to target +11%
🎯 on HQY : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Nov 13, 26
Keybanc ↗
Oct 8, 25
▲ Overweight · 🎯$120
Price at call : $92.09 — upside +30%
Today : $90.19 — upside +33%
Expected +30% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 67% (3 calls matureds) · 📊 on Health : 31.9% · -11.8% (47 calls)
+1.0%
stock +1% · XLV +16%
matured Oct 8, 26
Jefferies ↗
Sep 3, 25
▲ Buy · 🎯$134
Price at call : $97.7 — upside +37%
Today : $90.19 — upside +49%
Expected +37% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (2 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
-1.7%
stock -2% · XLV +25%
matured Sep 3, 26
JP Morgan ↗
Sep 3, 25
▲ Overweight · 🎯$126
Price at call : $97.7 — upside +29%
Today : $90.19 — upside +40%
Expected +29% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
-1.7%
stock -2% · XLV +25%
matured Sep 3, 26
▲ Outperform · 🎯$125
Price at call : $97.7 — upside +28%
Today : $90.19 — upside +39%
Expected +28% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-1.7%
stock -2% · XLV +25%
matured Sep 3, 26
RBC Capital ↗
Sep 3, 25
▲ Outperform · 🎯$110
Price at call : $97.7 — upside +13%
Today : $90.19 — upside +22%
Expected +13% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
-1.7%
stock -2% · XLV +25%
matured Sep 3, 26
▲ Outperform · 🎯$125
Price at call : $89.33 — upside +40%
Today : $90.19 — upside +39%
Expected +40% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+8.1%
stock +8% · XLV +24%
matured Aug 29, 26
RBC Capital ↗
Aug 28, 25
▲ Outperform · 🎯$109
Price at call : $88.29 — upside +23%
Today : $90.19 — upside +21%
Expected +23% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+9.2%
stock +9% · XLV +25%
matured Aug 28, 26
Raymond James ↗
Jul 8, 25
▲ Strong Buy · 🎯$120
Price at call : $99.98 — upside +20%
Today : $90.19 — upside +33%
Expected +20% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (3 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-5.2%
stock -5% · XLV +20%
matured Jul 8, 26
Jefferies ↗
Jun 11, 25
▲ Buy · 🎯$130
Price at call : $103.99 — upside +25%
Today : $90.19 — upside +44%
Expected +25% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (2 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
-15.0%
stock -15% · XLV +12%
matured Jun 11, 26
▲ Outperform · 🎯$125
Price at call : $111.55 — upside +12%
Today : $90.19 — upside +39%
Expected +12% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-21.3%
stock -21% · XLV +14%
matured Jun 5, 26
Deutsche Bank ↗
Jun 5, 25
▲ Buy · 🎯$115
Price at call : $111.55 — upside +3%
Today : $90.19 — upside +28%
Expected +3% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
-21.3%
stock -21% · XLV +14%
matured Jun 5, 26
Goldman Sachs ↗
Jun 4, 25
■ Neutral neutral · not a buy · 🎯$104
Price at call : $112.7 — gap to target -8%
Today : $90.19 — gap to target +15%
🎯 on HQY : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Jun 4, 26
RBC Capital ↗
Jun 4, 25
▲ Outperform · 🎯$117
Price at call : $112.7 — upside +4%
Today : $90.19 — upside +30%
Expected +4% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
-21.3%
stock -21% · XLV +15%
matured Jun 4, 26
▲ Buy · 🎯$125
Price at call : $112.7 — upside +11%
Today : $90.19 — upside +39%
Expected +11% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
-21.3%
stock -21% · XLV +15%
matured Jun 4, 26
▲ Market Outperform · 🎯$117
Price at call : $112.7 — upside +4%
Today : $90.19 — upside +30%
Expected +4% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (2 calls matureds) · 📊 unranked overall
-21.3%
stock -21% · XLV +15%
matured Jun 4, 26
Keybanc ↗
Apr 16, 25
▲ Overweight · 🎯$100
Price at call : $82.49 — upside +21%
Today : $90.19 — upside +11%
Expected +21% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 67% (3 calls matureds) · 📊 on Health : 31.9% · -11.8% (47 calls)
+2.5%
stock +2% · XLV +8%
matured Apr 16, 26
▲ Outperform · 🎯$112
Price at call : $82.2 — upside +36%
Today : $90.19 — upside +24%
Expected +36% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-2.8%
stock -3% · XLV +8%
matured Apr 11, 26
Goldman Sachs ↗
Mar 27, 25
■ Neutral neutral · not a buy · 🎯$94
Price at call : $86.96 — gap to target +8%
Today : $90.19 — gap to target +4%
🎯 on HQY : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Mar 27, 26
Raymond James ↗
Mar 25, 25
▲ Strong Buy · 🎯$115
Price at call : $90.19 — upside +28%
Today : $90.19 — upside +28%
Expected +28% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (3 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-8.6%
stock -9% · XLV +1%
matured Mar 25, 26
Keybanc ↗
Mar 24, 25
▲ Overweight · 🎯$110
Price at call : $90.32 — upside +22%
Today : $90.19 — upside +22%
Expected +22% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 67% (3 calls matureds) · 📊 on Health : 31.9% · -11.8% (47 calls)
-9.1%
stock -9% · XLV -2%
matured Mar 24, 26
Deutsche Bank ↗
Mar 20, 25
▲ Buy · 🎯$98
Price at call : $84.6 — upside +16%
Today : $90.19 — upside +9%
Expected +16% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
-4.2%
stock -4% · XLV -1%
matured Mar 20, 26
▲ Outperform · 🎯$112
Price at call : $84.6 — upside +32%
Today : $90.19 — upside +24%
Expected +32% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-4.2%
stock -4% · XLV -1%
matured Mar 19, 26
▲ Outperform · 🎯$112
Price at call : $97.41 — upside +15%
Today : $90.19 — upside +24%
Expected +15% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-19.2%
stock -19% · XLV +4%
matured Mar 14, 26
Wells Fargo ↗
Feb 26, 25
▲ Overweight · 🎯$125
Price at call : $105.61 — upside +18%
Today : $90.19 — upside +39%
Expected +18% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (1 call matured) · 📊 on Health : 47.4% · +5.1% (152 calls)
-26.7%
stock -27% · XLV +6%
matured Feb 26, 26
Raymond James ↗
Feb 25, 25
▲ Outperform · 🎯$120
Price at call : $105.61 — upside +14%
Today : $90.19 — upside +33%
Expected +14% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 0% (3 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-26.7%
stock -27% · XLV +6%
matured Feb 25, 26
Deutsche Bank ↗
Jan 14, 25
▲ Buy · 🎯$108
Price at call : $103.61 — upside +4%
Today : $90.19 — upside +20%
Expected +4% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
-17.4%
stock -17% · XLV +13%
matured Jan 14, 26
JMP Securities
Dec 10, 24
▲ Market Outperform · 🎯$107
Price at call : $97.36 — upside +10%
Today : $90.19 — upside +19%
Expected +10% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (2 calls matureds) · 📊 unranked overall
+0.0%
stock +0% · XLV +8%
matured Dec 10, 25
RBC Capital ↗
Dec 10, 24
▲ Outperform · 🎯$105
Price at call : $97.36 — upside +8%
Today : $90.19 — upside +16%
Expected +8% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+0.0%
stock +0% · XLV +8%
matured Dec 10, 25
▲ Outperform · 🎯$120
Price at call : $101.66 — upside +18%
Today : $90.19 — upside +33%
Expected +18% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
-2.7%
stock -3% · XLV +5%
matured Dec 2, 25
▲ Outperform · 🎯$105
Price at call : $79.2 — upside +33%
Today : $90.19 — upside +16%
Expected +33% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+21.2%
stock +21% · XLV -12%
matured Sep 20, 25
▲ Outperform · 🎯$105
Price at call : $79.49 — upside +32%
Today : $90.19 — upside +16%
Expected +32% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+15.1%
stock +15% · XLV -11%
matured Sep 5, 25
Deutsche Bank ↗
Sep 4, 24
▲ Buy · 🎯$103
Price at call : $79.49 — upside +30%
Today : $90.19 — upside +14%
Expected +30% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+15.1%
stock +15% · XLV -11%
matured Sep 4, 25
RBC Capital ↗
Sep 4, 24
▲ Outperform · 🎯$92
Price at call : $79.49 — upside +16%
Today : $90.19 — upside +2%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+15.1%
stock +15% · XLV -11%
matured Sep 4, 25
▲ Outperform · 🎯$105
Price at call : $78.63 — upside +34%
Today : $90.19 — upside +16%
Expected +34% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+13.0%
stock +13% · XLV -12%
matured Aug 30, 25
▲ Outperform · 🎯$105
Price at call : $84.84 — upside +24%
Today : $90.19 — upside +16%
Expected +24% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+32.8%
stock +33% · XLV -9%
matured Jun 4, 25
RBC Capital ↗
Jun 4, 24
▲ Outperform · 🎯$92
Price at call : $84.84 — upside +8%
Today : $90.19 — upside +2%
Expected +8% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+32.8%
stock +33% · XLV -9%
matured Jun 4, 25
▲ Outperform · 🎯$100
Price at call : $79.38 — upside +26%
Today : $90.19 — upside +11%
Expected +26% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 50% (12 calls matureds) · 📊 on Health : 29.5% · -9.7% (78 calls)
+13.8%
stock +14% · XLV +1%
matured Mar 22, 25
RBC Capital ↗
Mar 20, 24
▲ Outperform · 🎯$92
Price at call : $82.2 — upside +12%
Today : $90.19 — upside +2%
Expected +12% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+3.3%
stock +3% · XLV +1%
matured Mar 20, 25
RBC Capital ↗
Feb 23, 24
▲ Outperform · 🎯$90
Price at call : $83.5 — upside +8%
Today : $90.19 — upside -0%
Expected +8% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+31.1%
stock +31% · XLV +0%
matured Feb 22, 25
Deutsche Bank ↗
Sep 7, 23
▲ Buy · 🎯$72
Price at call : $68.03 — upside +6%
Today : $90.19 — upside -20%
Expected +6% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+12.2%
stock +12% · XLV +17%
matured Sep 6, 24
RBC Capital ↗
Sep 6, 23
▲ Outperform · 🎯$77
Price at call : $71.38 — upside +8%
Today : $90.19 — upside -15%
Expected +8% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+6.8%
stock +7% · XLV +17%
matured Sep 5, 24
Deutsche Bank ↗
Jun 7, 23
▲ Buy · 🎯$71
Price at call : $63.38 — upside +12%
Today : $90.19 — upside -21%
Expected +12% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+34.5%
stock +35% · XLV +13%
matured Jun 6, 24
RBC Capital ↗
Jun 6, 23
▲ Outperform · 🎯$75
Price at call : $65.38 — upside +15%
Today : $90.19 — upside -17%
Expected +15% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+28.0%
stock +28% · XLV +13%
matured Jun 5, 24
Deutsche Bank ↗
Mar 24, 23
▲ Buy · 🎯$69
Price at call : $57.69 — upside +20%
Today : $90.19 — upside -23%
Expected +20% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+37.6%
stock +38% · XLV +14%
matured Mar 23, 24
RBC Capital ↗
Mar 22, 23
▲ Outperform · 🎯$75
Price at call : $57.14 — upside +31%
Today : $90.19 — upside -17%
Expected +31% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+43.9%
stock +44% · XLV +16%
matured Mar 21, 24
Deutsche Bank ↗
Jan 24, 23
▲ Buy · 🎯$72
Price at call : $58.93 — upside +22%
Today : $90.19 — upside -20%
Expected +22% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+31.2%
stock +31% · XLV +4%
matured Jan 24, 24
RBC Capital ↗
Dec 5, 22
▲ Outperform · 🎯$75
Price at call : $67.73 — upside +11%
Today : $90.19 — upside -17%
Expected +11% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (12 calls matureds) · 📊 on Health : 48.8% · +6.8% (201 calls)
+1.9%
stock +2% · XLV -5%
matured Dec 5, 23
Deutsche Bank ↗
Sep 8, 22
▲ Buy · 🎯$68
Price at call : $65.98 — upside +3%
Today : $90.19 — upside -25%
Expected +3% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+3.1%
stock +3% · XLV +2%
matured Sep 8, 23
Deutsche Bank ↗
Jun 8, 22
▲ Buy · 🎯$67
Price at call : $63.85 — upside +5%
Today : $90.19 — upside -26%
Expected +5% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
-0.7%
stock -1% · XLV -0%
matured Jun 8, 23
Deutsche Bank ↗
Mar 24, 22
▲ Buy · 🎯$66
Price at call : $63.03 — upside +5%
Today : $90.19 — upside -27%
Expected +5% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
-11.1%
stock -11% · XLV -6%
matured Mar 24, 23
Deutsche Bank ↗
Feb 24, 22
▲ Buy · 🎯$62
Price at call : $53.25 — upside +16%
Today : $90.19 — upside -31%
Expected +16% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 58% (12 calls matureds) · 📊 on Health : 53.8% · +9.7% (80 calls)
+22.4%
stock +22% · XLV -2%
matured Feb 24, 23
▲ Overweight · 🎯$85
Price at call : $81.44 — upside +4%
Today : $90.19 — upside -6%
Expected +4% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-21.6%
stock -22% · XLV +7%
matured Jun 8, 22
▲ Overweight · 🎯$70
Price at call : $58.29 — upside +20%
Today : $90.19 — upside -22%
Expected +20% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+39.1%
stock +39% · XLV +20%
matured Jun 3, 21
▲ Overweight · 🎯$80
Price at call : $42.02 — upside +90%
Today : $90.19 — upside -11%
Expected +90% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+74.7%
stock +75% · XLV +32%
matured Mar 17, 21
▲ Overweight · 🎯$82
Price at call : $61.95 — upside +32%
Today : $90.19 — upside -9%
Expected +32% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+22.9%
stock +23% · XLV +18%
matured Dec 18, 19
Chardan Capital
Mar 20, 18
▲ Buy · 🎯$77
Price at call : $64.54 — upside +19%
Today : $90.19 — upside -15%
Expected +19% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 100% (4 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+23.4%
stock +23% · XLV +9%
matured Mar 20, 19
▲ Overweight · 🎯$60
Price at call : $50.99 — upside +18%
Today : $90.19 — upside -33%
Expected +18% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+40.5%
stock +41% · XLV +11%
matured Feb 7, 19
▲ Overweight · 🎯$50
Price at call : $41.73 — upside +20%
Today : $90.19 — upside -45%
Expected +20% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+44.7%
stock +45% · XLV +7%
matured Mar 31, 18
Chardan Capital
Mar 22, 17
▲ Buy · 🎯$53
Price at call : $43.83 — upside +21%
Today : $90.19 — upside -41%
Expected +21% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on HQY : 100% (4 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+52.4%
stock +52% · XLV +9%
matured Mar 22, 18
▲ Buy · 🎯$47
Price at call : $43.54 — upside +8%
Today : $90.19 — upside -48%
Expected +8% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 100% (4 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+14.7%
stock +15% · XLV +17%
matured Feb 7, 18
Chardan Capital
Dec 13, 16
▲ Buy · 🎯$50
Price at call : $41.86 — upside +19%
Today : $90.19 — upside -45%
Expected +19% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on HQY : 100% (4 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+6.4%
stock +6% · XLV +20%
matured Dec 13, 17

Frequently asked questions

Should I buy HealthEquity stock?

This isn't buy advice. For HealthEquity, the analyst consensus is "Buy", with an average price target of $113 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on HealthEquity). We show the numbers — you decide.

Is it too late to buy HealthEquity? How high can it go?

The most bullish analyst target on HealthEquity is $142 (+57% above today's price); the average is $113. That's the upside they see. Check how reliable those analysts have actually been on HealthEquity on our site before trusting it.

Is HealthEquity still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on HealthEquity, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in HealthEquity? The case for and against

The arguments for and against, one by one, from the numbers: why invest in HQY (and why hesitate).

What has HealthEquity's past performance been?

Historical returns and a "how much if I had invested" calculator: HQY performance & returns.

What is the best month to buy HQY?

The 12 months ranked by the stock's past returns: best & worst month to buy HQY.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)